STING1 and breast carcinoma: To determine the clinical relevance of our findings above, we further analyzed scRNA‐seq data on MSCs in the clinical samples described above (Figure 1B)[23] and found that STING was upregulated in breast cancer MSCs compared to that in MSCs from normal breast tissues (Figure 8A).